Sue Hartigan <[EMAIL PROTECTED]> writes:
Hi Terry:
That wasn't a news story, it came off the American Cancer Society home
page.
Sue
> Hi Sue,
>
> No hype, huh?
>
> >Sue Hartigan <[EMAIL PROTECTED]> writes:
>
> >New drug combination eliminates cancer in mice
>
> >...hailed as "the single most exciting thing on the horizon" of cancer
> >treatment by Dr. Richard Klausner, National Cancer Institute Director.
>
> [Is this anybody's idea of a considered scientific evaluation of a possible
> future cancer treatment? Can anybody spell hyperbole? I assure you many
> others are sure they have the best thing available.]
>
> >Because clinical trials of angiostatin and endostatin are not yet
> >underway, patients may consider clinical trials of other
> >anti-angiogenesis drugs such as TNP-470, carboxyamidotriazole, anti-VEGF,
> or >thalidomide,
>
> [Some may remember that last drug. In its previous incarnation it was, of
> course, an anti-nausea drug that had some rather notable side effects that
> weren't discovered quickly.]
>
> >The American Cancer Society spends over 91 million dollars on cancer
> >research each year, including several angiogenesis research projects.
>
> [Several, huh? New idea?]
>
> I deleted all the usual cautions that not everyone reads but are
> indisputably included in news stories. Warnings on a pack of cigarettes
> would have stopped smoking if people always paid attention to the fine print.
> Best, Terry
--
Two rules in life:
1. Don't tell people everything you know.
2.
Subscribe/Unsubscribe, email: [EMAIL PROTECTED]
In the body of the message enter: subscribe/unsubscribe law-issues
